Vaxcyte (PCVX) Shares Issued (2019 - 2026)

Vaxcyte (PCVX) has 8 years of Shares Issued data on file, last reported at $9.0 million in Q1 2026.

• Shares Issued for Q1 2026 came in at $9.0 million, up 49.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.0 million (down 43.24% YoY), and the FY2025 annual result was $13.0 million, down 52.09% from the prior year.
• Shares Issued grew to $9.0 million in Q1 2026 per PCVX's latest filing, from $3.4 million in the prior quarter.
• Over five years, Shares Issued peaked at $51.8 million in Q2 2022 and troughed at -$89.3 million in Q4 2022.
• A 5-year average of $3.7 million and a median of $4.4 million in 2024 frame the typical range for Shares Issued.
• The sharpest annual moves came in 2022 and 2023: Shares Issued sank 1335.85% in 2022, then surged 14718.09% in 2023.
• A 5-year view of Shares Issued shows it stood at -$89.3 million in 2022, then jumped by 104.6% to $4.1 million in 2023, then jumped by 45.77% to $6.0 million in 2024, then tumbled by 42.93% to $3.4 million in 2025, then jumped by 164.48% to $9.0 million in 2026.
• Business Quant data shows PCVX's Shares Issued at $9.0 million in Q1 2026, $3.4 million in Q4 2025, and $306000.0 in Q3 2025.